CTRE enters its Q1 2026 earnings call with short sellers clearly pulling back — and the borrowing market too loose to suggest any urgency from the other side.
Short interest has collapsed by a third over the past month, falling to roughly 4.7% of the free float from a peak near 7% in mid-March. That unwind accelerated sharply around April 23, when shares on loan dropped by almost five million in a single session. The borrow market reflects no lingering conviction from bears: cost to borrow is just 0.49%, and availability is wide open — the share lending pool is nearly untapped relative to current short positions. The short score of 39 sits in the bottom third of the universe, confirming the positioning is far from aggressive.
The bull case rests on two pillars: operating momentum and a conservative balance sheet. Consensus sits at nine buy ratings and zero sells, with a mean target of $43.75 — about 11% above Thursday's close of $39.50. Analysts point to the company's low leverage, strong tenant credit, and AFFO trajectory tracking toward roughly $2.19 per share, which underpins the Outperform ratings from Mizuho (initiated in April) and RBC Capital, which lifted its target to $44 in February. The bear case is softer: regulatorty uncertainty around skilled nursing facilities, new tenant execution risk, and competition for senior housing assets. It is a debate about pace and risk management, not about the fundamental direction of the business. The EPS surprise factor score ranks in the 73rd percentile, meaning the company has a history of beating estimates. The stock is up 5.6% over the past month and 9.2% year-to-date — momentum that gives bulls added comfort heading into the print.
One institutional detail worth noting: BlackRock added over 7.5 million shares through April, lifting its stake to nearly 14.7% of shares outstanding. That is a material accumulation for a fund of that size and signals conviction at the institutional level. Peer performance has been mixed over the past week — WELL gained 2.1% and SBRA edged up 0.7%, while OHI fell 1.4% and NHI dropped 3.4% — leaving CTRE's 12.7% weekly gain looking notably strong and possibly reflecting some pre-earnings positioning rather than pure sector tailwinds.
The Q1 report will test whether AFFO growth and deployment activity justify a stock that has re-rated sharply from its March lows — and whether the bull consensus holds up once the numbers land.
See the live data behind this article on ORTEX.
Open CTRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
